176 related articles for article (PubMed ID: 24518539)
1. Synthesis, spectroscopic and DFT structural characterization of two novel ruthenium(III) oxicam complexes. In vivo evaluation of anti-inflammatory and gastric damaging activities.
Tamasi G; Bernini C; Corbini G; Owens NF; Messori L; Scaletti F; Massai L; Giudice PL; Cini R
J Inorg Biochem; 2014 May; 134():25-35. PubMed ID: 24518539
[TBL] [Abstract][Full Text] [Related]
2. Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.
Aman F; Hanif M; Kubanik M; Ashraf A; Söhnel T; Jamieson SM; Siddiqui WA; Hartinger CG
Chemistry; 2017 Apr; 23(20):4893-4902. PubMed ID: 28198061
[TBL] [Abstract][Full Text] [Related]
3. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions.
Mügge C; Liu R; Görls H; Gabbiani C; Michelucci E; Rüdiger N; Clement JH; Messori L; Weigand W
Dalton Trans; 2014 Feb; 43(8):3072-86. PubMed ID: 24169734
[TBL] [Abstract][Full Text] [Related]
4. Diverse in vitro and in vivo anti-inflammatory effects of trichlorido-gold(III) complexes with N6-benzyladenine derivatives.
Křikavová R; Hošek J; Suchý P; Vančo J; Trávníček Z
J Inorg Biochem; 2014 May; 134():92-9. PubMed ID: 24584156
[TBL] [Abstract][Full Text] [Related]
5. Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)-piroxicam and -isoxicam complex molecules.
Tamasi G; Serinelli F; Consumi M; Magnani A; Casolaro M; Cini R
J Inorg Biochem; 2008 Oct; 102(10):1862-73. PubMed ID: 18667239
[TBL] [Abstract][Full Text] [Related]
6. Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties.
Battistin F; Scaletti F; Balducci G; Pillozzi S; Arcangeli A; Messori L; Alessio E
J Inorg Biochem; 2016 Jul; 160():180-8. PubMed ID: 26920229
[TBL] [Abstract][Full Text] [Related]
7. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
Chakraborty S; Bose M; Sarkar M
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium(II) bipyridine complexes bearing new keto-enol azoimine ligands: synthesis, structure, electrochemistry and DFT calculations.
Al-Noaimi M; Awwadi FF; Mansi A; Abdel-Rahman OS; Hammoudeh A; Warad I
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():828-39. PubMed ID: 25150434
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory active gold(I) complexes involving 6-substituted-purine derivatives.
Trávníček Z; Starha P; Vančo J; Silha T; Hošek J; Suchý P; Pražanová G
J Med Chem; 2012 May; 55(10):4568-79. PubMed ID: 22541000
[TBL] [Abstract][Full Text] [Related]
10. Coordination modes of bidentate lornoxicam drug with some transition metal ions. Synthesis, characterization and in vitro antimicrobial and antibreastic cancer activity studies.
Mahmoud WH; Mohamed GG; El-Dessouky MM
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():598-608. PubMed ID: 24334061
[TBL] [Abstract][Full Text] [Related]
11. The interactions of the ruthenium(II)-cymene complexes with lysozyme and cytochrome c.
Stanic-Vucinic D; Nikolic S; Vlajic K; Radomirovic M; Mihailovic J; Cirkovic Velickovic T; Grguric-Sipka S
J Biol Inorg Chem; 2020 Mar; 25(2):253-265. PubMed ID: 32020293
[TBL] [Abstract][Full Text] [Related]
12. Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)-isoxicam, -meloxicam and -cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex.
Cini R; Tamasi G; Defazio S; Hursthouse MB
J Inorg Biochem; 2007 Aug; 101(8):1140-52. PubMed ID: 17592742
[TBL] [Abstract][Full Text] [Related]
13. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination for oxicam non-steroidal anti-inflammatory drugs in human serum by liquid chromatography-tandem mass spectrometry.
Shirako J; Kawasaki M; Komine K; Kunisue Y; Terada M; Sasaki C; Irie W; Murakami C; Tonooka K; Tomobe K; Shinozuka T
Forensic Sci Int; 2013 Apr; 227(1-3):100-2. PubMed ID: 23273940
[TBL] [Abstract][Full Text] [Related]
15. Increasing the bioavailability of Ru(III) anticancer complexes through hydrophobic albumin interactions.
Webb MI; Wu B; Jang T; Chard RA; Wong EW; Wong MQ; Yapp DT; Walsby CJ
Chemistry; 2013 Dec; 19(50):17031-42. PubMed ID: 24203647
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
[TBL] [Abstract][Full Text] [Related]
17. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
Dömötör O; Aicher S; Schmidlehner M; Novak MS; Roller A; Jakupec MA; Kandioller W; Hartinger CG; Keppler BK; Enyedy ÉA
J Inorg Biochem; 2014 May; 134():57-65. PubMed ID: 24556426
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.
Łakomska I; Fandzloch M; Muzioł T; Lis T; Jezierska J
Dalton Trans; 2013 May; 42(17):6219-26. PubMed ID: 23328694
[TBL] [Abstract][Full Text] [Related]
19. NO Releasing and Anticancer Properties of Octahedral Ruthenium-Nitrosyl Complexes with Equatorial 1 H-Indazole Ligands.
Orlowska E; Babak MV; Dömötör O; Enyedy EA; Rapta P; Zalibera M; Bučinský L; Malček M; Govind C; Karunakaran V; Farid YCS; McDonnell TE; Luneau D; Schaniel D; Ang WH; Arion VB
Inorg Chem; 2018 Sep; 57(17):10702-10717. PubMed ID: 30106571
[TBL] [Abstract][Full Text] [Related]
20. Heterotrimetallic Ru(II)/Pd(II)/Ru(II) complexes: synthesis, crystalstructure, spectral characterization, DFT calculation and antimicrobial study.
Al-Noaimi M; Nafady A; Warad I; Alshwafy R; Husein A; Talib WH; Hadda TB
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():273-82. PubMed ID: 24316542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
